FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers Post author:PacConAdmin Post published:July 29, 2025 Post category:Uncategorized Post comments:0 Comments FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers Source: FDA Press Releases Tags: aaps Read more articles Previous PostFDA Recommends Removal of Voluntary Hold for Elevidys for Ambulatory Patients Next PostFDA Requires Major Changes to Opioid Pain Medication Labeling to Emphasize Risks You Might Also Like FDA Begins Real-Time Reporting of Adverse Event Data August 22, 2025 Krystal Biotech Sells PVA for $100M to Undisclosed Buyer August 21, 2023 Cordis Recall of Angiographic Catheter for Lack of Sterilization Deemed Class I December 6, 2023 Leave a Reply Cancel replyCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Save my name, email, and website in this browser for the next time I comment.